Search clinical trials for: Unresectable hepatocellular carcinoma

Total 31065 results

Abbott

Completed

A Long Term Safety Study With Atrasentan

Adenocarcinoma | Prostate Cancer

Canada, United States, France, Netherlands, United Kingdom
Abbott

Completed

A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Abbott

Completed

A Study of ABT-751 in Patients With Renal Cell Cancer

Renal Cell Cancer

Canada, United States
Grupo Portugues de Estudo do Cancro do Pulmao

Unknown

Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC (Coimbra)

Carcinoma, Non-Small-Cell Lung

Portugal
Geriatric Oncology Consortium
Sanofi

Terminated

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

Neoplasm Metastasis | Colorectal Cancer

United States
Ministry of Scientific Research and Information...

Terminated

RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus

Esophageal Neoplasms | Squamous Cell Cancer

Poland
University of Saskatchewan

Completed

Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC

Non Small Cell Lung Cancer

Canada
Eli Lilly and Company

Completed

A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Associacio catalana per a la recerca oncologica...
Hoffmann-La Roche

Unknown

XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

Rectal Neoplasms | Locally Advanced Rectal Adenocarcinoma

Spain
University Hospital, Limoges
Groupe Français de Pneumologie Cancérologie (GFPC)

Completed

Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer

Non Small Cell Lung Carcinoma

France
James A. Haley Veterans Administration Hospital
Hoffmann-La Roche

Terminated

Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma

Colorectal Cancer

United States
Eli Lilly and Company

Completed

Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell-Lung Cancer

Turkey
Eli Lilly and Company

Completed

2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen

Urologic Neoplasms | Carcinoma, Transitional Cell

Japan
InterMune

Terminated

Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer

Peritoneal Carcinoma | Ovarian Carcinoma

United States
Kentuckiana Cancer Institute

Completed

Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
University Hospital, Limoges

Completed

Follow-up of Patients With Curative-Intent Surgical Resection for NSCLC

Non-Small Cell Lung Cancer

France
Gruppo Italiano MEsotelioma

Unknown

A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma

Mesothelioma

Italy
Neovii Biotech

Completed

Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma

Gastric Cancer | Gastric Adenocarcinoma

Germany
Ontario Clinical Oncology Group (OCOG)

Completed

Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the Prostate

Prostate Cancer

Canada
AstraZeneca

Completed

Evaluation of QoL, Tolerability and Use of Zoladex 10,8 SafeSystem for Advanced PCa - German IPEP Trial

Prostate Carcinoma
Sanofi

Completed

TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN

Carcinoma, Squamous Cell

Korea, Republic of
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center; Connective Tissue Oncology Society; Massachusetts... and other collaborators

Completed

Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma

Sarcoma, Soft Tissue

United States
Gruppo Italiano per lo studio dei Carcinomi dell...
Mario Negri Institute for Pharmacological Research

Completed

Gemcitabine/Cisplatin +/-Cetuximab in Patients With Locally Advanced or Metastatic EGFR-Positive Pancreatic Cancer (SPaCe-01)

Pancreatic Cancer

Italy
Quadram Institute Bioscience

Completed

Broccoli, Peas and PIN

Prostatic Intraepithelial Neoplasia
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck

Carcinoma, Adenoid Cystic | Cancer of the Head and Neck

France
London North West Healthcare NHS Trust

Unknown

Adenoma Detection Rate:NBI, AFI, Chromoscopic or Standard Endoscopy

Familial Adenomatous Polyposis

United Kingdom
National Institute of Cancerología

Unknown

Hydralazine Valproate for Ovarian Cancer

Ovarian Cancer

Mexico
Introgen Therapeutics

Unknown

Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone

Carcinoma, Squamous Cell

United States
Heidelberg University

Unknown

Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer (OVAR-IMRT-01)

Ovarian Cancer

Germany
Intarcia Therapeutics

Terminated

Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer

Breast Neoplasms | Neoplasms, Hormone-Dependent

United States, Ukraine, Canada, Russian Federation
National Cancer Institute, Naples

Completed

END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin

Endometrial Cancer

Italy
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery

Oropharyngeal Neoplasms

France
Intarcia Therapeutics

Terminated

The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Breast Neoplasms | Neoplasms, Hormone-Dependent

United States, Romania, Russian Federation, Ukraine, Bulgaria
ARCAGY/ GINECO GROUP
Hoffmann-La Roche

Terminated

Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer

Ovarian Cancer

France
Abbott

Completed

Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma

Carcinoma, Renal Cell

United States, Netherlands
Abbott

Terminated

Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

United States
Eli Lilly and Company
Gynecologic Oncology Group

Completed

A Trial for Patients With Gestational Trophoblastic Disease

Uterine Neoplasms | Trophoblastic Neoplasms | Hydatidiform Mole | Choriocarcinoma

United States
University Hospital, Montpellier
University Hospital, Angers; University Hospital, Rouen; University Hospital,... and other collaborators

Terminated

Comparison Between Colorectal Stents and Primary Surgery in Obstructive Colonic Cancer. A Randomized, Controlled Study

Colorectal Obstruction | Left Colonic Adenocarcinoma
Adherex Technologies, Inc.

Completed

A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection

Neoplasms

United States
National Taiwan University Hospital
Mackay Memorial Hospital; Taipei Veterans General Hospital, Taiwan; National... and other collaborators

Completed

Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer

Gastric Cancer

Taiwan
National Taiwan University Hospital

Completed

Weekly TP-HDFL in the Treatment of Advanced TCC

Transitional Cell Carcinoma

Taiwan
National Taiwan University Hospital

Completed

Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Taiwan
National Taiwan University Hospital

Completed

Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC

Transitional Cell Carcinoma

Taiwan
Weill Medical College of Cornell University

Terminated

Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer

Head and Neck Cancer

United States
McGill University Health Centre/Research Institute...

Unknown

Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer

Pain | Breast Cancer | Prostate Cancer | Vertebral Metastasis

Canada
Tianjin Medical University

Unknown

A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer

Breast Cancer

China
Eli Lilly and Company

Completed

Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes

Non-Small Cell Lung Cancer

Poland
Eli Lilly and Company

Completed

Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian Cancer

Epithelial Ovarian Cancer

Slovakia
Eli Lilly and Company

Completed

Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas

Biliary Tract Carcinoma

Korea, Republic of
Eli Lilly and Company

Completed

Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy

Non-Small Cell Lung Cancer

Germany, Italy, United Kingdom

3

Subscribe